Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 637-648 of 1,743
Device study icon
Active Not RecruitingNCT07007481

Purrble's Soothing Touch for Eating disorders and Autism

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Eating disordersDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Eating disorders
Drug study icon
CompletedEUCTR 2005-003251-13

Quetiapine Augmentation In Treatment-Resistant Depression – An Open Pilot Study

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrugA study involving a medication or substance.
Countries
United Kingdom
Sponsor
AstraZeneca UK Ltd
Condition
Depression
Drug study icon
CompletedEUCTR 2015-004271-78

Randomised controlled trial of the short term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
ADHDDrug
Countries
United Kingdom
Sponsor
King's College London
Condition
ADHD
Drug study icon
CompletedNCT00763971

Safety study of Lisdexamfetamine Dimesylate (LDX) in ADHD

This study is completed in France, in the United Kingdom, in Belgium, .... It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.

In United Kingdom
ADHDDrugFrom 6 Years to 17 Years
Countries
France, United Kingdom, Belgium, ...
Sponsor
Shire
Condition
ADHD
Drug study icon
TerminatedEUCTR 2006-003519-33

RAPID - An Open-Label, Randomised, Multicentre Phase IIIb Study to Evaluate the Efficacy and Tolerability of Quetiapine IR (Immedicate Release), over 14 days, in Acute Schizophrenia / Schizoaffecti...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
SchizophreniaDrug
Countries
United Kingdom
Sponsor
AstraZeneca UK Limited
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2011-005218-13

Rationalisation of antipsychotic drug use in older people, using [18F]-Fallypride PET

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
SchizophreniaDrug
Countries
United Kingdom
Sponsor
Kings College London [...] 1. Kings College London 2. South London and Maudsley NHS Foundation Trust
Condition
Schizophrenia
Behavioral study icon
CompletedNCT06691646

RECOGNeyes Gaze-Control Training

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
ADHDBehavioralFrom 18 Years to 30 Years
Countries
United Kingdom
Sponsor
University of Nottingham
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.